Application 021402

Type
NDA
Sponsor
ABBVIE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001SYNTHROIDLEVOTHYROXINE SODIUMTABLET;ORAL0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumYesNo
002SYNTHROIDLEVOTHYROXINE SODIUMTABLET;ORAL0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumYesNo
003SYNTHROIDLEVOTHYROXINE SODIUMTABLET;ORAL0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumYesNo
004SYNTHROIDLEVOTHYROXINE SODIUMTABLET;ORAL0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumYesNo
005SYNTHROIDLEVOTHYROXINE SODIUMTABLET;ORAL0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumYesNo
006SYNTHROIDLEVOTHYROXINE SODIUMTABLET;ORAL0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumYesNo
007SYNTHROIDLEVOTHYROXINE SODIUMTABLET;ORAL0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumYesNo
008SYNTHROIDLEVOTHYROXINE SODIUMTABLET;ORAL0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumYesNo
009SYNTHROIDLEVOTHYROXINE SODIUMTABLET;ORAL0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumYesNo
010SYNTHROIDLEVOTHYROXINE SODIUMTABLET;ORAL0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumYesNo
011SYNTHROIDLEVOTHYROXINE SODIUMTABLET;ORAL0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumYesYes
012SYNTHROIDLEVOTHYROXINE SODIUMTABLET;ORAL0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumYesNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 12 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N021402-001SYNTHROIDLEVOTHYROXINE SODIUM0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-24
N021402-002SYNTHROIDLEVOTHYROXINE SODIUM0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-24
N021402-003SYNTHROIDLEVOTHYROXINE SODIUM0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-24
N021402-004SYNTHROIDLEVOTHYROXINE SODIUM0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-24
N021402-005SYNTHROIDLEVOTHYROXINE SODIUM0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-24
N021402-006SYNTHROIDLEVOTHYROXINE SODIUM0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-24
N021402-007SYNTHROIDLEVOTHYROXINE SODIUM0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-24
N021402-008SYNTHROIDLEVOTHYROXINE SODIUM0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-24
N021402-009SYNTHROIDLEVOTHYROXINE SODIUM0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-24
N021402-010SYNTHROIDLEVOTHYROXINE SODIUM0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-24
N021402-011SYNTHROIDLEVOTHYROXINE SODIUM0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD, RS2002-07-24
N021402-012SYNTHROIDLEVOTHYROXINE SODIUM0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-24

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 24 matching rows.

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 13 · 492 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02N021402-001SYNTHROID0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-24011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021402-002SYNTHROID0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-24011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021402-003SYNTHROID0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-24011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021402-004SYNTHROID0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-24011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021402-005SYNTHROID0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-24011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021402-006SYNTHROID0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-24011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021402-007SYNTHROID0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-24011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021402-008SYNTHROID0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-24011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021402-009SYNTHROID0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-24011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021402-010SYNTHROID0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-24011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021402-011SYNTHROID0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD, RS2002-07-24011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021402-012SYNTHROID0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-24011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021402-001SYNTHROID0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-2431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021402-002SYNTHROID0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-2431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021402-003SYNTHROID0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-2431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021402-004SYNTHROID0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-2431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021402-005SYNTHROID0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-2431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021402-006SYNTHROID0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-2431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021402-007SYNTHROID0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-2431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021402-008SYNTHROID0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-2431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021402-009SYNTHROID0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-2431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021402-010SYNTHROID0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-2431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021402-011SYNTHROID0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD, RS2002-07-2431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021402-012SYNTHROID0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-2431067a03dcf5…
2025-08-23 18:47 UTC2025-08N021402-001SYNTHROID0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-246a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021402-002SYNTHROID0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-246a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021402-003SYNTHROID0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-246a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021402-004SYNTHROID0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-246a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021402-005SYNTHROID0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-246a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021402-006SYNTHROID0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-246a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021402-007SYNTHROID0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-246a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021402-008SYNTHROID0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-246a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021402-009SYNTHROID0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-246a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021402-010SYNTHROID0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-246a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021402-011SYNTHROID0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD, RS2002-07-246a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021402-012SYNTHROID0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-246a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021402-001SYNTHROID0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-24fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021402-002SYNTHROID0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-24fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021402-003SYNTHROID0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-24fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021402-004SYNTHROID0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2RLD2002-07-24fd3edfee7708…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 25 · 984 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-02-19 14:30 UTC2026-02N021402-001AB11011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021402-001AB22011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021402-002AB11011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021402-002AB22011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021402-003AB11011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021402-003AB22011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021402-004AB11011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021402-004AB22011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021402-005AB11011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021402-005AB22011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021402-006AB11011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021402-006AB22011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021402-007AB11011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021402-007AB22011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021402-008AB11011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021402-008AB22011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021402-009AB11011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021402-009AB22011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021402-010AB11011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021402-010AB22011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021402-011AB11011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021402-011AB22011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021402-012AB11011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021402-012AB22011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021402-001AB1131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021402-001AB2231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021402-002AB1131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021402-002AB2231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021402-003AB1131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021402-003AB2231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021402-004AB1131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021402-004AB2231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021402-005AB1131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021402-005AB2231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021402-006AB1131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021402-006AB2231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021402-007AB1131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021402-007AB2231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021402-008AB1131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021402-008AB2231067a03dcf5…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SynthroidLEVOTHYROXINE SODIUMAbbVie Inc.1e11ad30-1041-4520-10b0-8f9d30d30fcc2024-02-20Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021402
application number: NDA021402
ndc (product): 0074-7070
ndc (product): 0074-7149
ndc (product): 0074-4341
ndc (product): 0074-4552
ndc (product): 0074-7148
ndc (product): 0074-6594
ndc (product): 0074-3727
ndc (product): 0074-5182
ndc (product): 0074-7068
ndc (product): 0074-9296
ndc (product): 0074-6624
ndc (product): 0074-7069

NDC Listings For This Application#

NDC listings for this application page 1 of 2 · 107 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0074-3727SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-3727SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-3727SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-3727SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-3727SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-3727SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-3727SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-4341SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-4341SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-4341SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-4341SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-4341SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-4341SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-4341SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-4552SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-4552SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-4552SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-4552SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-4552SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-4552SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-4552SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-5182SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-5182SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-5182SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-5182SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-5182SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-5182SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-5182SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-6594SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-6594SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-6594SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-6594SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-6594SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-6594SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-6594SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-6624SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-6624SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-6624SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-6624SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-6624SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-6624SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-6624SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7068SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7068SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7068SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7068SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7068SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7068SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7068SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7069SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7069SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7069SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7069SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7069SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7069SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7069SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7070SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7070SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7070SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7070SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7070SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7070SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7070SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7148SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7148SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7148SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7148SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7148SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7148SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7148SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7149SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7149SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7149SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7149SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7149SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7149SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-7149SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-9296SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-9296SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent
0074-9296SynthroidLevothyroxine SodiumAbbVie Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
77586SUPPL 2024-02-21
77590SUPPL 2024-02-20
71979SUPPL2022-08-31
71974SUPPL2022-08-31
63965SUPPL2020-07-20
63938SUPPL2020-07-16
47414SUPPL2017-03-02
47413SUPPL2017-03-02
47325SUPPL2017-02-24
47324SUPPL2017-02-24
15373SUPPL2014-01-15
5258SUPPL2012-10-02
27675SUPPL2008-07-15
15372SUPPL2008-07-15
36822SUPPL2008-06-05
42138ORIG2002-11-25
27674ORIG2002-07-24
15371ORIG2002-07-24